A lawsuit has been filed against a major agricultural biotechnology corporation, alleging that their popular herbicide product, Roundup, caused significant health issues due to its active ingredient, glyphosate. Clare Dauzart initiated the complaint in the United States District Court for the Middle District of Louisiana on September 26, 2024, targeting Monsanto Company as the defendant.
The plaintiff, Clare Dauzart, claims that exposure to Monsanto's Roundup led to her development of non-Hodgkin’s lymphoma. She asserts that Monsanto was negligent in designing, manufacturing, and marketing Roundup without proper warnings about its potential dangers. According to the complaint, glyphosate is defective and hazardous to human health and should not have been marketed without adequate safety instructions. The lawsuit highlights a broader issue affecting thousands across the country who have suffered similar injuries allegedly linked to glyphosate exposure.
Dauzart's case outlines several accusations against Monsanto. It alleges that Monsanto engaged in fraudulent misrepresentation by downplaying the risks associated with glyphosate and falsely advertising Roundup as safe for humans and the environment. The complaint references a 2015 evaluation by the International Agency for Research on Cancer (IARC), which classified glyphosate as "probably carcinogenic to humans," linking it specifically to non-Hodgkin’s lymphoma and other cancers. Despite this classification and other studies indicating genotoxicity and carcinogenicity risks associated with glyphosate, Monsanto continued promoting Roundup as safe.
The lawsuit accuses Monsanto of violating various federal regulations under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) by failing to conduct adequate safety testing and providing misleading information about Roundup's safety profile. Additionally, it claims that Monsanto engaged in efforts to suppress or discredit scientific research highlighting glyphosate's potential health risks through ghostwritten studies and undue influence over regulatory assessments.
In seeking justice from the court, Dauzart requests compensatory damages for her medical expenses, pain and suffering, lost wages, and diminished quality of life resulting from her illness. She also seeks punitive damages against Monsanto for their alleged willful misconduct in concealing the true dangers of their product. Furthermore, she demands a jury trial to address all issues raised in her complaint.
Representing Clare Dauzart are attorneys from various law firms specializing in personal injury cases related to chemical exposure. The case is presided over by Judge John W. deGravelles with Magistrate Judge Richard L. Bourgeois Jr., under Case ID 3:24-cv-00801-JWD-RLB.